WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011151403) IMPROVED CANCER THERAPY BASED ON TUMOR ASSOCIATED ANTIGENS DERIVED FROM CYCLIN D1
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/151403    International Application No.:    PCT/EP2011/059121
Publication Date: 08.12.2011 International Filing Date: 01.06.2011
IPC:
A61K 38/04 (2006.01), A61K 39/00 (2006.01), A61K 45/06 (2006.01), C07K 14/47 (2006.01), A61P 35/00 (2006.01)
Applicants: IMMATICS BIOTECHNOLOGIES GMBH [DE/DE]; Paul-Ehrlich-Strasse 15 72076 Tuebingen (DE) (For All Designated States Except US).
SINGH, Harpreet [DE/DE]; (DE) (For US Only).
WEINSCHENK, Toni [DE/DE]; (DE) (For US Only).
WALTER, Steffen [DE/DE]; (DE) (For US Only)
Inventors: SINGH, Harpreet; (DE).
WEINSCHENK, Toni; (DE).
WALTER, Steffen; (DE)
Agent: KRAUSS, Jan B.; Boehmert & Boehmert Pettenkoferstrasse 20 - 22 80336 Munich (DE)
Priority Data:
1009222.9 02.06.2010 GB
61/350,731 02.06.2010 US
Title (EN) IMPROVED CANCER THERAPY BASED ON TUMOR ASSOCIATED ANTIGENS DERIVED FROM CYCLIN D1
(FR) CANCÉROTHÉRAPIE AMÉLIORÉE BASÉE SUR DES ANTIGÈNES ASSOCIÉS À UNE TUMEUR DÉRIVÉS DE LA CYCLINE D1
Abstract: front page image
(EN)The present invention relates to cyclin D1-derived peptides for use in the improved treatment of cancer in a patient, particularly in the form of a combination therapy using a vaccine. Other aspects relate to the use of the peptides or a combination thereof as a diagnostic tool.
(FR)La présente invention concerne des peptides dérivés de la cycline D1 à utiliser dans le traitement amélioré d'un cancer chez un patient, notamment sous la forme d'une polythérapie utilisant un vaccin. D'autres aspects concernent l'utilisation des peptides ou une combinaison de ceux-ci en tant qu'outil de diagnostic.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)